Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Evaluating Lapatinib + Capecitabine in Patients Aged 70 and Over With HER2 Metastatic Breast Cancer. (GERICO09)

This study has been completed.
Information provided by (Responsible Party):
UNICANCER Identifier:
First received: December 16, 2010
Last updated: December 14, 2014
Last verified: December 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2013
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)